Parkside Financial Bank & Trust’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.12K Buy
+1,000
New +$6.53K ﹤0.01% 1833
2023
Q3
– Sell
-19
Closed -$126 – 2112
2023
Q2
$126 Sell
19
-607
-97% -$3.89K ﹤0.01% 1985
2023
Q1
$4.25K Buy
626
+284
+83% +$2K ﹤0.01% 1422
2022
Q4
$2.53K Hold
342
– – ﹤0.01% 1599
2022
Q3
$3K Buy
+342
New +$3.61K ﹤0.01% 1466
2022
Q2
– Sell
-13
Closed – – 1967
2022
Q1
$0 Sell
13
-257
-95% -$3.38K ﹤0.01% 1945
2021
Q4
$4K Buy
270
+133
+97% +$2.32K ﹤0.01% 1434
2021
Q3
$2K Sell
137
-16
-10% -$280 ﹤0.01% 1610
2021
Q2
$3K Buy
153
+16
+12% +$286 ﹤0.01% 1474
2021
Q1
$2K Hold
137
– – ﹤0.01% 1538
2020
Q4
$2K Buy
+137
New +$1.65K ﹤0.01% 1460
2020
Q3
– Sell
-30
Closed – – 1658
2020
Q2
$0 Sell
30
-4
-12% -$45 ﹤0.01% 1708
2020
Q1
$0 Sell
34
-39
-53% -$484 ﹤0.01% 1669
2019
Q4
$1K Hold
73
– – ﹤0.01% 1492
2019
Q3
$1K Hold
73
– – ﹤0.01% 1469
2019
Q2
$1K Buy
73
+13
+22% +$207 ﹤0.01% 1482
2019
Q1
$1K Buy
60
+16
+36% +$365 ﹤0.01% 1441
2018
Q4
$1K Buy
+44
New +$1.03K ﹤0.01% 1341

Other funds holding VNDA

Parkside Financial Bank & Trust's VNDA Position: Q2 2026 in Review

Parkside Financial Bank & Trust opened a new position in Vanda Pharmaceuticals (VNDA) in Q2 2026: 1,000 shares worth $6.12K. The stake represents ﹤0.01% of the portfolio and ranks #1833 among its holdings. This is a return to the name: Parkside Financial Bank & Trust previously reported a position in VNDA as recently as Q2 2023.

Parkside Financial Bank & Trust first reported a position in VNDA in Q4 2018 and has held it in 18 quarters since. 172 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

  • Parkside Financial Bank & Trust held 1,000 shares of Vanda Pharmaceuticals worth $6.12K as of Q2 2026.
  • Vanda Pharmaceuticals was a new Parkside Financial Bank & Trust position in Q2 2026.
  • Vanda Pharmaceuticals made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #1833 holding.
  • Parkside Financial Bank & Trust first reported a position in Vanda Pharmaceuticals in Q4 2018 and has held it in 18 quarters since.
  • 172 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.